A Prospective Evaluation of Neurocognitive Function and Neurologic Symptoms in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Undergoing Anti-CD22 Chimeric Antigen Receptor Therapy Shalabi, H., Wolters, P. L., Martin, S., Delbrook, C., Yates, B., Lee, D. W., Mackall, C. L., Fry, T. J., Shah, N. N. AMER SOC HEMATOLOGY. 2016

View details for Web of Science ID 000394452305021